I agree with you on NNVC. I see little indication they will move away from their core viral/nano tech. But, I see nano medicines as being wide open; and if inclined to, I don't see why NNVC could not pursue additional markets--especially bacterial and veterinary.
I scanned a SA article this morning about MKND and its inhalable diabetes (insulin) tech. I'll go back and review it later. I don't think it is nano related (but maybe). My interest: diabetes is a huge market, and technologies which gets patients away from needles and injections towards more passive techniques will be huge.
Lots going on in the nano and bio arenas. With all the players involved; including private, scholarly, and governmental, it's very difficult to keep up.
Thanks for your input.
Market Data 
Markets 
